1
|
1
|
1
|
1
|
|
HLA + Diamond–Blackfan anemia 9 (DBA9)
|
RPS10
|
AD
|
1
|
1
|
2
|
2
|
1
|
1
|
|
HLA + ectodermal dysplasia, hypohidrotic, with immune deficiency
|
IKBKG
|
XL
|
2
|
9
|
6
|
8
|
2
|
2
|
|
HLA + Fanconi anemia, complementation group A (FANCA)
|
FANCA
|
AR
|
18
|
52
|
29
|
43
|
14
|
10
|
|
HLA + Fanconi anemia, complementation group C (FANCC)
|
FANCC
|
AR
|
2
|
5
|
5
|
8
|
1
|
1
|
|
HLA + Fanconi anemia, complementation group D2 (FANCD2)
|
FANCD2
|
AR
|
1
|
3
|
2
|
3
|
1
|
1
|
|
HLA + Fanconi anemia, complementation group F (FANCF)
|
FANCF
|
AR
|
2
|
5
|
2
|
3
|
0
|
0
|
|
HLA + Fanconi anemia, complementation group G (FANCG)
|
FANCG
|
AR
|
2
|
2
|
2
|
3
|
2
|
2
|
|
HLA + Fanconi anemia, complementation group I (FANCI)
|
FANCI
|
AR
|
1
|
2
|
2
|
3
|
0
|
0
|
|
HLA + Fanconi anemia, complementation group J (FANCJ)
|
BRIP1
|
AR
|
1
|
1
|
1
|
1
|
1
|
1
|
|
HLA + Fanconi anemia, complementation group JI (FANCJ)
|
BRIP1
|
AR
|
1
|
3
|
1
|
3
|
0
|
0
|
|
HLA + Glanzmann thrombasthenia (GT, +DMD)
|
ITGA2B DMD
|
|
1
|
2
|
2
|
4
|
1
|
0
|
|
HLA + granulomatous disease, chronic, autosomal recessive, cytochrome b‐positive, type I (CDG1)
|
NCF1
|
AR
|
1
|
3
|
2
|
2
|
1
|
1
|
|
HLA + granulomatous disease, chronic, X‐linked (CDGX)
|
CYBB
|
XL
|
6
|
16
|
13
|
17
|
7
|
6
|
|
HLA + hemoglobin‐beta locus (HBB)
|
HBB
|
AR
|
92
|
188
|
119
|
177
|
41
|
31
|
|
HLA + hyper‐IgE recurrent infection syndrome, autosomal recessive
|
DOCK8
|
AR
|
1
|
1
|
0
|
0
|
0
|
0
|
|
HLA + Krabbe disease
|
GALC
|
AR
|
1
|
1
|
1
|
2
|
1
|
1
|
|
HLA + myotonic dystrophy 1 (DM1)
|
DMPK
|
AD
|
1
|
2
|
1
|
2
|
1
|
1
|
|
HLA + neutropenia, severe congenital, 1, autosomal dominant (SCN1)
|
ELANE
|
AD
|
2
|
3
|
2
|
5
|
2
|
1
|
|
HLA + polycystic kidney disease 1 (PKD1)
|
PKD1
|
AD
|
1
|
1
|
1
|
